Life Sciences Opportunities in India & China: From Innovation to Commercialization
30 September 2009
China and India are emerging as major players in the life sciences industry. Both countries have a wealth of top talent as well as rapidly-improving resources for the industry. Both countries also constitute important current and potential markets for drugs, devices and diagnostics, and are also projected to be major sources of innovation in the not-too-distant future. This panel will explore the significant opportunities in China and India, in terms not only of expanding operations to both countries, but also in terms of working with innovative companies that originate from China and India.
Moderator:
- David A. Charapp, Special Counsel, Foley & Lardner LLP
Panelists:
- Stephen A. Bent, Partner, Foley & Lardner LLP
- Friedhelm Blobel, Ph.D., President, CEO, Director, SciClone Pharmaceuticals
- Kim Kamdar, Ph.D., Principal at Domain Associates
- Sanjay Shukla, M.D., M.S., Chief Executive Officer, RxMD
Related Insights
24 October 2024
Events
The Future of AI in the Consumer Goods Industry
Join us on October 24 for a panel made up of Artificial Intelligence (AI) experts from academia and industry.
07 October 2024
Labor & Employment Law Perspectives
Illinois Updates Its Law Governing Use of Staffing Agencies — Again
The Illinois General Assembly has been busy at work revising and updating the Illinois Day and Temporary Labor Services Act.
07 October 2024
Labor & Employment Law Perspectives
Disappearing Messages, Unofficial Communications Platforms and Ever-Increasing Scrutiny by Regulators
Corporate use of third-party messaging platforms, including ephemeral messaging tools (which allow messages to disappear), is quite common and has become both a cost efficiency for employers and a convenient way for employees to communicate quickly with colleagues and clients.